SMOFLIPID

SMOFLIPID was reported 874 times

SMOFLIPID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FAT OVERLOAD SYNDROME 4 0.4444
1 FATTY ACID DEFICIENCY 31 0.3780
2 PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE 25 0.2809
3 LACTOBACILLUS TEST POSITIVE 4 0.1905
4 CHYLURIA 1 0.1250
5 STOMA SITE THROMBOSIS 1 0.0909
6 NUTRITIONAL SUPPLEMENT ALLERGY 1 0.0769
7 MANUFACTURING PROCESS CONTROL PROCEDURE ISSUE 2 0.0690
8 SCAR INFLAMMATION 2 0.0571
9 MANGANESE DECREASED 1 0.0526
10 MILK SOY PROTEIN INTOLERANCE 1 0.0500
11 MANUFACTURING LABORATORY ANALYTICAL TESTING ISSUE 1 0.0500
12 VITAMIN E INCREASED 1 0.0476
13 BACILLUS BACTERAEMIA 5 0.0459
14 PROTEIN ALBUMIN RATIO DECREASED 1 0.0455
15 LACTASE DEFICIENCY 1 0.0455
16 MALASSEZIA INFECTION 3 0.0441
17 CULTURE NEGATIVE 1 0.0417
18 PANTOEA AGGLOMERANS INFECTION 3 0.0390
19 DIVERSION COLITIS 1 0.0303
20 NEONATAL INTESTINAL PERFORATION 1 0.0278
21 NEONATAL HYPERGLYCAEMIA 1 0.0270
22 CATHETER SITE NECROSIS 1 0.0263
23 MALIGNANT ATROPHIC PAPULOSIS 1 0.0250
24 CITROBACTER SEPSIS 1 0.0250
25 SENSORY PROCESSING SENSITIVITY 1 0.0227
26 BACILLUS TEST POSITIVE 2 0.0202
27 ALEXITHYMIA 1 0.0200
28 VITAMIN E DECREASED 1 0.0189
29 HIV ANTIBODY POSITIVE 1 0.0185
30 LACTOBACILLUS INFECTION 3 0.0183
31 GASTROINTESTINAL STOMA OUTPUT DECREASED 2 0.0142
32 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 2 0.0138
33 BLOOD PRESSURE SYSTOLIC 1 0.0135
34 MICROCOCCUS INFECTION 1 0.0123
35 NEONATAL CHOLESTASIS 1 0.0119
36 BACILLUS INFECTION 7 0.0111
37 URINARY TRACT STOMA COMPLICATION 1 0.0106
38 MYELOCYTE COUNT INCREASED 2 0.0106
39 INTESTINE TRANSPLANT REJECTION 1 0.0104
40 GASTROSTOMY TUBE SITE COMPLICATION 2 0.0100
41 DEVICE PROGRAMMING ERROR 3 0.0095
42 CITROBACTER INFECTION 4 0.0093
43 SERRATIA SEPSIS 1 0.0093
44 KLEBSIELLA TEST POSITIVE 6 0.0092
45 COPPER DEFICIENCY 1 0.0083
46 NEONATAL HYPONATRAEMIA 1 0.0082
47 MYOCARDIAL DEPRESSION 2 0.0078
48 INTENTIONAL PRODUCT MISUSE TO CHILD 1 0.0078
49 NECROTISING ENTEROCOLITIS NEONATAL 3 0.0074
50 HYPERVITAMINOSIS 1 0.0072
51 STOMA PROLAPSE 1 0.0070
52 TOTAL BILE ACIDS INCREASED 1 0.0068
53 GASTROINTESTINAL STOMA OUTPUT INCREASED 3 0.0064
54 SEPSIS NEONATAL 5 0.0062
55 VASCULAR DEVICE OCCLUSION 2 0.0059
56 GROWTH FAILURE 2 0.0058
57 LARGE INTESTINAL ULCER HAEMORRHAGE 2 0.0058
58 PRODUCT PACKAGING CONFUSION 14 0.0058
59 BILE ACIDS INCREASED 1 0.0056
60 BLOOD ZINC DECREASED 1 0.0055
61 PRODUCT COMPOUNDING QUALITY ISSUE 2 0.0055
62 HYPERTRIGLYCERIDAEMIA 31 0.0053
63 POOR WEIGHT GAIN NEONATAL 1 0.0051
64 CATHETER SITE EXTRAVASATION 2 0.0050
65 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 1 0.0044
66 FEEDING INTOLERANCE 2 0.0044
67 LENNOX-GASTAUT SYNDROME 1 0.0044
68 STOMA COMPLICATION 4 0.0039
69 ADENOIDAL DISORDER 1 0.0038
70 VASCULAR DEVICE INFECTION 17 0.0037
71 OVERGROWTH BACTERIAL 1 0.0037
72 DEVICE RELATED SEPSIS 7 0.0035
73 ABDOMINAL SEPSIS 3 0.0034
74 ENTEROBACTER BACTERAEMIA 1 0.0033
75 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
76 DEVICE RELATED BACTERAEMIA 1 0.0032
77 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 4 0.0032
78 CARBON DIOXIDE ABNORMAL 1 0.0032
79 BACTERIAL PYELONEPHRITIS 1 0.0030
80 COLOSTOMY CLOSURE 1 0.0029
81 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
82 HEPATITIS B VIRUS TEST POSITIVE 1 0.0026
83 NEUROBLASTOMA 1 0.0026
84 BILIRUBIN CONJUGATED INCREASED 6 0.0026
85 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 2 0.0025
86 PERIPHERAL CIRCULATORY FAILURE 1 0.0024
87 THROMBOCYTOPENIA NEONATAL 1 0.0024
88 PANCREATIC ATROPHY 1 0.0023
89 NITRITE URINE PRESENT 1 0.0023
90 GASTRIC FISTULA 1 0.0022
91 CONGESTIVE HEPATOPATHY 1 0.0022
92 CATHETER SITE RASH 1 0.0022
93 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
94 PROTHROMBIN TIME SHORTENED 3 0.0021
95 CATHETER SITE SWELLING 2 0.0021
96 AIR EMBOLISM 1 0.0021
97 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
98 FAECAL VOLUME DECREASED 1 0.0021
99 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
100 BODY HEIGHT INCREASED 1 0.0020
101 SEPSIS SYNDROME 1 0.0020
102 FAECAL VOLUME INCREASED 1 0.0019
103 HYPERLIPASAEMIA 1 0.0019
104 FUNGAEMIA 3 0.0019
105 ENTEROCOCCAL BACTERAEMIA 2 0.0019
106 FEBRILE BONE MARROW APLASIA 8 0.0019
107 FAECAL VOMITING 1 0.0019
108 PRODUCT COMMINGLING 2 0.0019
109 COATING IN MOUTH 1 0.0019
110 PRODUCT NAME CONFUSION 2 0.0018
111 ENTEROBACTER INFECTION 3 0.0018
112 OCCIPITAL NEURALGIA 1 0.0018
113 CARBON DIOXIDE DECREASED 2 0.0017
114 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
115 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
116 BLOOD PHOSPHORUS DECREASED 6 0.0016
117 BODY TEMPERATURE ABNORMAL 3 0.0016
118 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
119 PARANEOPLASTIC SYNDROME 1 0.0015
120 INJECTION SITE NECROSIS 3 0.0015
121 STOMA SITE DISCHARGE 4 0.0015
122 INFUSION SITE RASH 2 0.0015
123 CHOLESTASIS 27 0.0014
124 HYPERNATRAEMIA 7 0.0014
125 COMA HEPATIC 1 0.0013
126 MENTAL FATIGUE 2 0.0013
127 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
128 METAPNEUMOVIRUS INFECTION 1 0.0013
129 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
130 BLOOD FIBRINOGEN INCREASED 1 0.0013
131 PUSTULE 3 0.0013
132 TACHYPNOEA 17 0.0012
133 PERFORATION 1 0.0012
134 VASCULAR ACCESS COMPLICATION 1 0.0012
135 BACTERIAL SEPSIS 4 0.0012
136 OXYGEN THERAPY 2 0.0012
137 FUNGAL SEPSIS 1 0.0012
138 TROPONIN I INCREASED 2 0.0012
139 TONSILLAR HYPERTROPHY 2 0.0012
140 HEPATIC CANCER METASTATIC 1 0.0012
141 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
142 CATHETER SITE PAIN 3 0.0012
143 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
144 CATHETER MANAGEMENT 1 0.0011
145 PNEUMONIA KLEBSIELLA 2 0.0011
146 BLOOD UREA ABNORMAL 1 0.0011
147 PYURIA 1 0.0010
148 WRONG DRUG ADMINISTERED 9 0.0010
149 DEVICE RELATED INFECTION 15 0.0010
150 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
151 BODY TEMPERATURE FLUCTUATION 2 0.0010
152 BLAST CELL COUNT INCREASED 1 0.0010
153 HYPOPERFUSION 1 0.0010
154 CATHETER SITE ERYTHEMA 2 0.0009
155 GALLBLADDER ENLARGEMENT 1 0.0009
156 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
157 RETROPERITONEAL HAEMATOMA 2 0.0009
158 CATHETER SITE DISCHARGE 1 0.0009
159 KLEBSIELLA SEPSIS 1 0.0009
160 PALMAR ERYTHEMA 1 0.0009
161 HEPATITIS CHOLESTATIC 5 0.0008
162 FEBRILE CONVULSION 1 0.0008
163 BLOOD MAGNESIUM DECREASED 7 0.0008
164 RETROPERITONEAL HAEMORRHAGE 2 0.0008
165 FISTULA DISCHARGE 1 0.0008
166 NECROTISING COLITIS 1 0.0008
167 BRONCHIAL SECRETION RETENTION 1 0.0008
168 INFUSION SITE IRRITATION 1 0.0008
169 OBSTRUCTION GASTRIC 1 0.0008
170 PLATELET TRANSFUSION 1 0.0008
171 BILIARY OBSTRUCTION 1 0.0008
172 RHINOVIRUS INFECTION 3 0.0008
173 SINUS ARRHYTHMIA 1 0.0008
174 COMPARTMENT SYNDROME 2 0.0008
175 HYPOVITAMINOSIS 1 0.0008
176 CHEILITIS 4 0.0007
177 ISCHAEMIC HEPATITIS 1 0.0007
178 MENINGITIS VIRAL 1 0.0007
179 ANAPHYLACTOID REACTION 3 0.0007
180 DRUG DISPENSING ERROR 11 0.0007
181 NECROSIS 4 0.0007
182 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
183 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
184 ESCHERICHIA SEPSIS 2 0.0007
185 WRONG PATIENT RECEIVED PRODUCT 2 0.0007
186 TEMPERATURE INTOLERANCE 7 0.0007
187 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
188 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
189 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
190 APNOEA 5 0.0006
191 BODY TEMPERATURE INCREASED 13 0.0006
192 HYPOGLYCAEMIA NEONATAL 1 0.0006
193 EROSIVE OESOPHAGITIS 1 0.0006
194 BACTERAEMIA 7 0.0006
195 FOOD AVERSION 1 0.0006
196 PSEUDOMONAL SEPSIS 1 0.0006
197 FOOD CRAVING 3 0.0006
198 HYPERCALCAEMIA 7 0.0006
199 JAUNDICE CHOLESTATIC 2 0.0006
200 LIVER FUNCTION TEST INCREASED 12 0.0006
201 CATHETER SITE INFECTION 2 0.0005
202 TRAUMATIC LUNG INJURY 1 0.0005
203 ELECTROLYTE IMBALANCE 6 0.0005
204 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
205 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
206 ANORECTAL DISORDER 1 0.0005
207 HYPERPHAGIA 2 0.0005
208 IMMUNE-MEDIATED HEPATITIS 1 0.0005
209 HYPERBILIRUBINAEMIA 5 0.0005
210 INFUSION SITE EXTRAVASATION 3 0.0005
211 BLOOD UREA INCREASED 8 0.0005
212 INFUSION SITE SWELLING 3 0.0005
213 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
214 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
215 HYPERPHOSPHATAEMIA 1 0.0005
216 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
217 CHOLESTATIC LIVER INJURY 1 0.0004
218 BACTERIAL TEST POSITIVE 1 0.0004
219 ILEUS PARALYTIC 2 0.0004
220 MALNUTRITION 5 0.0004
221 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
222 RENAL FUNCTION TEST ABNORMAL 2 0.0004
223 CHOLELITHIASIS 14 0.0004
224 ESCHERICHIA BACTERAEMIA 1 0.0004
225 PRODUCT SUPPLY ISSUE 3 0.0004
226 HYPERLIPIDAEMIA 5 0.0004
227 WEIGHT ABNORMAL 1 0.0004
228 SINUS BRADYCARDIA 4 0.0004
229 BLOOD BILIRUBIN INCREASED 11 0.0004
230 DEVICE INFUSION ISSUE 1 0.0004
231 CATHETER SITE HAEMORRHAGE 1 0.0004
232 VENOOCCLUSIVE DISEASE 1 0.0004
233 SYSTEMIC CANDIDA 1 0.0004
234 URINARY TRACT INFECTION BACTERIAL 1 0.0004
235 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
236 ABDOMINAL INFECTION 1 0.0004
237 CANCER PAIN 1 0.0004
238 INCREASED BRONCHIAL SECRETION 1 0.0004
239 INTENTIONAL PRODUCT USE ISSUE 34 0.0004
240 PERIORBITAL OEDEMA 2 0.0004
241 HYPERLACTACIDAEMIA 1 0.0004
242 JAUNDICE 10 0.0004
243 LIVER INJURY 9 0.0004
244 BLOOD PHOSPHORUS INCREASED 1 0.0004
245 RASH MORBILLIFORM 1 0.0004
246 STREPTOCOCCAL INFECTION 2 0.0004
247 ANAL HAEMORRHAGE 1 0.0004
248 CHOLECYSTITIS ACUTE 2 0.0004
249 HEPATOCELLULAR INJURY 5 0.0004
250 HYPOGLYCAEMIA 17 0.0004
251 ADENOVIRUS INFECTION 1 0.0003
252 STRIDOR 1 0.0003
253 GROWTH RETARDATION 1 0.0003
254 ENERGY INCREASED 2 0.0003
255 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
256 URINE ANALYSIS ABNORMAL 1 0.0003
257 ATYPICAL PNEUMONIA 1 0.0003
258 METABOLIC ENCEPHALOPATHY 1 0.0003
259 CENTRAL VENOUS CATHETERISATION 1 0.0003
260 DERMATITIS ACNEIFORM 2 0.0003
261 PRODUCT DISTRIBUTION ISSUE 3 0.0003
262 SWELLING OF EYELID 2 0.0003
263 ABDOMINAL ADHESIONS 1 0.0003
264 RECALLED PRODUCT ADMINISTERED 3 0.0003
265 ACUTE RESPIRATORY FAILURE 6 0.0003
266 HAEMOGLOBIN ABNORMAL 2 0.0003
267 ANAPHYLACTIC SHOCK 8 0.0003
268 PORTAL VEIN THROMBOSIS 1 0.0003
269 THROMBOSIS IN DEVICE 1 0.0003
270 BODY TEMPERATURE DECREASED 3 0.0003
271 APPETITE DISORDER 2 0.0003
272 LYME DISEASE 1 0.0003
273 CEREBRAL HAEMATOMA 1 0.0003
274 HAEMATURIA 10 0.0003
275 NEPHROTIC SYNDROME 2 0.0003
276 HEPATIC FIBROSIS 1 0.0003
277 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
278 PRIAPISM 1 0.0003
279 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
280 FEELING COLD 8 0.0003
281 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
282 FEAR OF INJECTION 2 0.0003
283 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
284 HYPERGLYCAEMIA 10 0.0003
285 FOOD INTOLERANCE 1 0.0003
286 AMYLASE INCREASED 1 0.0003
287 HYPOPHOSPHATAEMIA 2 0.0003
288 INTESTINAL PERFORATION 3 0.0003
289 CHILLS 31 0.0003
290 INTERNAL HAEMORRHAGE 3 0.0003
291 HYPERTHERMIA 2 0.0003
292 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
293 ACIDOSIS 2 0.0003
294 BOWEL MOVEMENT IRREGULARITY 2 0.0003
295 FOOD ALLERGY 2 0.0003
296 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
297 HYPOALBUMINAEMIA 2 0.0003
298 MULTIPLE ALLERGIES 2 0.0003
299 PNEUMONIA FUNGAL 1 0.0003
300 BLOOD ALBUMIN DECREASED 2 0.0003
301 CEREBRAL ATROPHY 1 0.0003
302 PRODUCT ADMINISTRATION ERROR 5 0.0002
303 VITAMIN B12 DEFICIENCY 1 0.0002
304 BLOOD POTASSIUM INCREASED 4 0.0002
305 SHOCK HAEMORRHAGIC 2 0.0002
306 ABNORMAL FAECES 2 0.0002
307 SMALL INTESTINAL OBSTRUCTION 3 0.0002
308 INJECTION SITE EXTRAVASATION 3 0.0002
309 INTESTINAL STENOSIS 1 0.0002
310 HEPATIC CYTOLYSIS 3 0.0002
311 CIRCULATORY COLLAPSE 4 0.0002
312 HYPOPHAGIA 6 0.0002
313 INFUSION SITE PAIN 3 0.0002
314 BLOOD POTASSIUM DECREASED 7 0.0002
315 METASTATIC NEOPLASM 1 0.0002
316 OCULAR ICTERUS 1 0.0002
317 SEPTIC SHOCK 10 0.0002
318 PARONYCHIA 1 0.0002
319 TUMOUR LYSIS SYNDROME 2 0.0002
320 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
321 SEPSIS 25 0.0002
322 HAEMOLYTIC ANAEMIA 2 0.0002
323 PANCREATITIS ACUTE 5 0.0002
324 URINE ABNORMALITY 1 0.0002
325 METABOLIC ACIDOSIS 7 0.0002
326 DISEASE COMPLICATION 1 0.0002
327 EAR DISORDER 1 0.0002
328 BACTERIAL INFECTION 4 0.0002
329 YELLOW SKIN 1 0.0002
330 DEVICE OCCLUSION 3 0.0002
331 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
332 SKIN ABRASION 1 0.0002
333 RASH VESICULAR 1 0.0002
334 THROMBOTIC MICROANGIOPATHY 2 0.0002
335 RENAL CELL CARCINOMA 1 0.0002
336 PHARYNGEAL SWELLING 2 0.0002
337 STAPHYLOCOCCAL SEPSIS 1 0.0002
338 HYPERVOLAEMIA 1 0.0002
339 HEPATIC ENZYME ABNORMAL 1 0.0002
340 PNEUMONIA ASPIRATION 5 0.0002
341 HYPERAMMONAEMIA 1 0.0002
342 CYTOKINE RELEASE SYNDROME 4 0.0002
343 HEPATIC FAILURE 6 0.0002
344 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
345 DYSPHORIA 1 0.0002
346 INSURANCE ISSUE 3 0.0002
347 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
348 VARICOSE VEIN 1 0.0002
349 SKIN NECROSIS 1 0.0002
350 FAILURE TO THRIVE 1 0.0002
351 TENDERNESS 2 0.0002
352 MALABSORPTION 1 0.0002
353 PARTIAL SEIZURES 1 0.0002
354 TRANSFUSION 2 0.0002
355 JOINT DISLOCATION 2 0.0002
356 RETCHING 4 0.0002
357 ANAL FISTULA 1 0.0002
358 PALLOR 5 0.0002
359 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
360 FAECALOMA 1 0.0002
361 NONSPECIFIC REACTION 1 0.0002
362 ANAPHYLACTIC REACTION 10 0.0002
363 CYSTIC FIBROSIS 1 0.0002
364 HYPERTENSIVE CRISIS 2 0.0002
365 INTRACRANIAL PRESSURE INCREASED 1 0.0002
366 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
367 INTERMENSTRUAL BLEEDING 1 0.0002
368 OXYGEN SATURATION DECREASED 10 0.0002
369 COLD SWEAT 3 0.0002
370 BLOOD CREATININE INCREASED 11 0.0002
371 THIRST 3 0.0002
372 PYREXIA 58 0.0002
373 PROTHROMBIN TIME PROLONGED 1 0.0002
374 DRUG INTOLERANCE 16 0.0002
375 INGUINAL HERNIA 1 0.0002
376 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
377 ACCIDENTAL OVERDOSE 6 0.0002
378 GENERALISED OEDEMA 2 0.0002
379 CHOLANGITIS 1 0.0002
380 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
381 HEPATITIS 4 0.0002
382 PROCTALGIA 1 0.0002
383 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
384 MUCOSAL INFLAMMATION 4 0.0002
385 POLYP 1 0.0002
386 BRADYCARDIA 8 0.0002
387 POST-TRAUMATIC STRESS DISORDER 1 0.0001
388 WRONG PRODUCT ADMINISTERED 1 0.0001
389 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
390 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
391 ABNORMAL LOSS OF WEIGHT 1 0.0001
392 ECCHYMOSIS 1 0.0001
393 PERIPHERAL COLDNESS 2 0.0001
394 RESPIRATORY DISTRESS 4 0.0001
395 DROOLING 1 0.0001
396 ENCEPHALITIS 1 0.0001
397 FORMICATION 1 0.0001
398 MOUTH ULCERATION 3 0.0001
399 BLOOD TEST ABNORMAL 2 0.0001
400 HYPONATRAEMIA 8 0.0001
401 THERMAL BURN 1 0.0001
402 EATING DISORDER 3 0.0001
403 RETINAL HAEMORRHAGE 1 0.0001
404 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
405 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
406 FAECES SOFT 1 0.0001
407 LIVER DISORDER 6 0.0001
408 HYDRONEPHROSIS 1 0.0001
409 GENERAL SYMPTOM 1 0.0001
410 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
411 PRODUCT USE ISSUE 25 0.0001
412 HEPATOCELLULAR CARCINOMA 1 0.0001
413 HAEMODYNAMIC INSTABILITY 1 0.0001
414 LIPASE INCREASED 1 0.0001
415 FEELING HOT 8 0.0001
416 MUSCULOSKELETAL CHEST PAIN 2 0.0001
417 NERVOUS SYSTEM DISORDER 4 0.0001
418 GASTROINTESTINAL INFLAMMATION 1 0.0001
419 CYANOSIS 2 0.0001
420 ABNORMAL BEHAVIOUR 5 0.0001
421 PRODUCT PRESCRIBING ERROR 3 0.0001
422 GINGIVAL PAIN 1 0.0001
423 CEREBRAL INFARCTION 3 0.0001
424 DECUBITUS ULCER 1 0.0001
425 ENCEPHALOPATHY 3 0.0001
426 ESCHERICHIA INFECTION 1 0.0001
427 INFUSION SITE ERYTHEMA 1 0.0001
428 THROMBOCYTOPENIA 13 0.0001
429 ANURIA 1 0.0001
430 ABDOMINAL DISTENSION 12 0.0001
431 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
432 URINE OUTPUT DECREASED 1 0.0001
433 NEUROTOXICITY 2 0.0001
434 EOSINOPHILIA 2 0.0001
435 HYPERKALAEMIA 4 0.0001
436 PRODUCT COMMUNICATION ISSUE 1 0.0001
437 LUNG INFILTRATION 1 0.0001
438 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
439 VOMITING 53 0.0001
440 RESPIRATORY RATE INCREASED 1 0.0001
441 GASTROINTESTINAL INFECTION 1 0.0001
442 LEUKOCYTOSIS 2 0.0001
443 C-REACTIVE PROTEIN INCREASED 4 0.0001
444 HYPOKALAEMIA 5 0.0001
445 HEPATIC FUNCTION ABNORMAL 4 0.0001
446 FLANK PAIN 1 0.0001
447 DYSARTHRIA 4 0.0001
448 BLOOD SODIUM DECREASED 2 0.0001
449 FEBRILE NEUTROPENIA 7 0.0001
450 PROTEINURIA 2 0.0001
451 INCREASED APPETITE 2 0.0001
452 RASH ERYTHEMATOUS 5 0.0001
453 INFECTION 15 0.0001
454 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
455 ASCITES 3 0.0001
456 COELIAC DISEASE 1 0.0001
457 THERAPY CHANGE 1 0.0001
458 TACHYCARDIA 9 0.0001
459 HEART RATE INCREASED 10 0.0001
460 BLOOD PRESSURE ABNORMAL 2 0.0001
461 RESPIRATORY DISORDER 3 0.0001
462 BRAIN INJURY 1 0.0001
463 PREMATURE BABY 3 0.0001
464 FEEDING DISORDER 2 0.0001
465 EPILEPSY 3 0.0001
466 DEHYDRATION 13 0.0001
467 PRODUCT PREPARATION ERROR 2 0.0001
468 EXPOSURE DURING PREGNANCY 6 0.0001
469 PULMONARY HYPERTENSION 2 0.0001
470 NERVOUSNESS 5 0.0001
471 SCRATCH 1 0.0001
472 SUDDEN DEATH 1 0.0001
473 MALAISE 41 0.0001
474 NIGHT SWEATS 3 0.0001
475 POOR QUALITY SLEEP 2 0.0001
476 LACTIC ACIDOSIS 3 0.0001
477 PHARYNGITIS STREPTOCOCCAL 1 0.0001
478 ASPIRATION 1 0.0001
479 STAPHYLOCOCCAL INFECTION 3 0.0001
480 INFUSION RELATED REACTION 6 0.0001
481 TOOTH DISORDER 2 0.0001
482 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
483 ORAL PAIN 2 0.0001
484 FISTULA 1 0.0001
485 MYOCARDITIS 1 0.0001
486 MUSCLE TWITCHING 2 0.0001
487 HYPOXIA 3 0.0001
488 BLOOD IRON DECREASED 1 0.0001
489 CEREBRAL HAEMORRHAGE 3 0.0001
490 MUSCLE RIGIDITY 1 0.0001
491 NO ADVERSE EVENT 15 0.0001
492 SUICIDE ATTEMPT 5 0.0001
493 STOMATITIS 5 0.0001
494 NOCTURIA 1 0.0001
495 RESPIRATORY FAILURE 6 0.0001
496 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
497 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
498 DERMATITIS ALLERGIC 1 0.0001
499 BRAIN OEDEMA 1 0.0001
500 MUSCLE ATROPHY 1 0.0001
501 SEIZURE 9 0.0001
502 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
503 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
504 BEDRIDDEN 1 0.0001
505 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
506 PANCREATITIS 4 0.0001
507 EAR INFECTION 2 0.0001
508 OEDEMA 4 0.0001
509 IMPAIRED GASTRIC EMPTYING 1 0.0001
510 GINGIVAL BLEEDING 1 0.0001
511 SKIN LESION 2 0.0001
512 RESPIRATORY ARREST 2 0.0001
513 SKIN REACTION 1 0.0001
514 FLATULENCE 4 0.0001
515 SINUS TACHYCARDIA 1 0.0001
516 HYPERHIDROSIS 9 0.0001
517 PARALYSIS 1 0.0001
518 MENTAL DISORDER 3 0.0001
519 FLUSHING 7 0.0001
520 APATHY 1 0.0001
521 CHEST DISCOMFORT 7 0.0001
522 URINARY INCONTINENCE 2 0.0001
523 DYSPNOEA 38 0.0001
524 IMMUNODEFICIENCY 1 0.0001
525 GASTROINTESTINAL DISORDER 6 0.0001
526 EPISTAXIS 5 0.0001
527 PLEURAL EFFUSION 4 0.0001
528 HYPERSENSITIVITY 12 0.0001
529 LIMB DISCOMFORT 2 0.0001
530 NAUSEA 51 0.0001
531 ACUTE MYELOID LEUKAEMIA 1 0.0001
532 CARDIAC DISORDER 6 0.0001
533 THERAPY PARTIAL RESPONDER 1 0.0001
534 DRUG-INDUCED LIVER INJURY 2 0.0001
535 ARRHYTHMIA 3 0.0001
536 PREMATURE DELIVERY 1 0.0001
537 BLOOD GLUCOSE DECREASED 3 0.0001
538 HIP FRACTURE 2 0.0001
539 MUSCLE TIGHTNESS 1 0.0001
540 BLOOD PRESSURE DECREASED 4 0.0001
541 CYTOMEGALOVIRUS INFECTION 1 0.0001
542 LEUKOPENIA 3 0.0001
543 CHEST PAIN 11 0.0001
544 OFF LABEL USE 52 0.0001
545 ACUTE KIDNEY INJURY 9 0.0001
546 PERIPHERAL SWELLING 9 0.0001
547 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
548 MULTI-ORGAN FAILURE 1 0.0001
549 WEIGHT DECREASED 16 0.0001
550 RASH MACULAR 2 0.0001
551 METASTASES TO LIVER 1 0.0001
552 ABDOMINAL PAIN 13 0.0001
553 GASTROENTERITIS VIRAL 1 0.0001
554 PELVIC PAIN 1 0.0001
555 TREMOR 9 0.0001
556 BLOOD GLUCOSE ABNORMAL 1 0.0001
557 CONJUNCTIVITIS 1 0.0001
558 DYSGEUSIA 4 0.0001
559 AGRANULOCYTOSIS 1 0.0001
560 HEPATIC STEATOSIS 1 0.0001
561 HYPOCALCAEMIA 1 0.0001
562 COLITIS 2 0.0001
563 BLOOD URINE PRESENT 1 0.0001
564 SLEEP APNOEA SYNDROME 1 0.0001
565 LETHARGY 3 0.0001
566 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
567 LOWER LIMB FRACTURE 1 0.0001
568 DRUG PRESCRIBING ERROR 1 0.0001
569 HERNIA 1 0.0001
570 ERUCTATION 1 0.0001
571 SINUS DISORDER 1 0.0001
572 DISORIENTATION 2 0.0001
573 HYPOTENSION 10 0.0000
574 OEDEMA PERIPHERAL 6 0.0000
575 NEUTROPHIL COUNT DECREASED 2 0.0000
576 TOXICITY TO VARIOUS AGENTS 8 0.0000
577 INTENTIONAL OVERDOSE 3 0.0000
578 IRRITABLE BOWEL SYNDROME 1 0.0000
579 DEEP VEIN THROMBOSIS 3 0.0000
580 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
581 FAECES DISCOLOURED 1 0.0000
582 DEVICE DISLOCATION 2 0.0000
583 PRODUCT DISPENSING ERROR 1 0.0000
584 MELAENA 1 0.0000
585 ANGIOEDEMA 2 0.0000
586 TRANSAMINASES INCREASED 1 0.0000
587 DIARRHOEA 29 0.0000
588 RASH PAPULAR 1 0.0000
589 CHROMATURIA 1 0.0000
590 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
591 PRODUCT AVAILABILITY ISSUE 1 0.0000
592 SKIN DISCOLOURATION 2 0.0000
593 SHOCK 1 0.0000
594 CONFUSIONAL STATE 7 0.0000
595 PNEUMONIA 14 0.0000
596 BURNING SENSATION 3 0.0000
597 NEUROPATHY PERIPHERAL 4 0.0000
598 COMA 2 0.0000
599 DEATH 36 0.0000
600 PRURITUS 16 0.0000
601 RASH 18 0.0000
602 PRODUCT DOSE OMISSION ISSUE 12 0.0000
603 COVID-19 7 0.0000
604 HALLUCINATION 3 0.0000
605 CELLULITIS 2 0.0000
606 HAEMATEMESIS 1 0.0000
607 DRUG RESISTANCE 1 0.0000
608 ILLNESS 4 0.0000
609 BACK PAIN 9 0.0000
610 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
611 RASH PRURITIC 2 0.0000
612 PNEUMONITIS 1 0.0000
613 ANAEMIA 7 0.0000
614 TREATMENT NONCOMPLIANCE 2 0.0000
615 MENTAL STATUS CHANGES 1 0.0000
616 MEDICATION ERROR 2 0.0000
617 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
618 RENAL IMPAIRMENT 3 0.0000
619 BLISTER 2 0.0000
620 SKIN EXFOLIATION 3 0.0000
621 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
622 DECREASED APPETITE 8 0.0000
623 LIVER FUNCTION TEST ABNORMAL 1 0.0000
624 MUSCULOSKELETAL STIFFNESS 3 0.0000
625 ABDOMINAL PAIN UPPER 7 0.0000
626 IRRITABILITY 2 0.0000
627 LACRIMATION INCREASED 1 0.0000
628 ILL-DEFINED DISORDER 2 0.0000
629 CONDITION AGGRAVATED 10 0.0000
630 BLOOD PRESSURE INCREASED 5 0.0000
631 MUSCLE SPASMS 6 0.0000
632 NASOPHARYNGITIS 6 0.0000
633 EMOTIONAL DISORDER 1 0.0000
634 BONE DENSITY DECREASED 1 0.0000
635 PULMONARY EMBOLISM 3 0.0000
636 CYSTITIS 1 0.0000
637 PAIN 19 0.0000
638 SWELLING FACE 2 0.0000
639 VIRAL INFECTION 1 0.0000
640 LIP SWELLING 1 0.0000
641 FUNGAL INFECTION 1 0.0000
642 SKIN DISORDER 1 0.0000
643 URINARY RETENTION 1 0.0000
644 ASTHENIA 11 0.0000
645 HAEMOGLOBIN DECREASED 3 0.0000
646 DELIRIUM 1 0.0000
647 NEOPLASM PROGRESSION 1 0.0000
648 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
649 OVERDOSE 6 0.0000
650 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
651 CRYING 1 0.0000
652 UNDERDOSE 2 0.0000
653 RESTLESSNESS 1 0.0000
654 AGITATION 2 0.0000
655 EYE SWELLING 1 0.0000
656 WEIGHT INCREASED 6 0.0000
657 INTESTINAL OBSTRUCTION 1 0.0000
658 UNEVALUABLE EVENT 2 0.0000
659 PLASMA CELL MYELOMA 1 0.0000
660 PARAESTHESIA 4 0.0000
661 DISEASE PROGRESSION 3 0.0000
662 ABORTION SPONTANEOUS 1 0.0000
663 DEVICE BREAKAGE 1 0.0000
664 DYSKINESIA 1 0.0000
665 ERYTHEMA 5 0.0000
666 CARDIAC ARREST 2 0.0000
667 POLLAKIURIA 1 0.0000
668 HEADACHE 15 0.0000
669 CARDIO-RESPIRATORY ARREST 1 0.0000
670 HYPERTENSION 5 0.0000
671 COLITIS ULCERATIVE 1 0.0000
672 PULMONARY OEDEMA 1 0.0000
673 THROAT IRRITATION 1 0.0000
674 ADVERSE DRUG REACTION 2 0.0000
675 THERAPY NON-RESPONDER 1 0.0000
676 ADVERSE EVENT 2 0.0000
677 RENAL DISORDER 1 0.0000
678 BLOOD CHOLESTEROL INCREASED 1 0.0000
679 COGNITIVE DISORDER 1 0.0000
680 COUGH 6 0.0000
681 ATRIAL FIBRILLATION 2 0.0000
682 DYSPEPSIA 2 0.0000
683 DIZZINESS 10 0.0000
684 FLUID RETENTION 1 0.0000
685 INJECTION SITE PAIN 6 0.0000
686 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
687 HOSPITALISATION 3 0.0000
688 INFLAMMATION 1 0.0000
689 HAEMORRHAGE 2 0.0000
690 ECZEMA 1 0.0000
691 PLATELET COUNT DECREASED 2 0.0000
692 HAEMATOCHEZIA 1 0.0000
693 INFLUENZA 2 0.0000
694 ABDOMINAL DISCOMFORT 3 0.0000
695 INCORRECT DOSE ADMINISTERED 4 0.0000
696 DYSPHONIA 1 0.0000
697 PALPITATIONS 2 0.0000
698 WHEEZING 1 0.0000
699 FEELING ABNORMAL 4 0.0000
700 RENAL FAILURE 2 0.0000
701 NEOPLASM MALIGNANT 1 0.0000
702 NEUTROPENIA 2 0.0000
703 HEPATIC ENZYME INCREASED 1 0.0000
704 MEMORY IMPAIRMENT 2 0.0000
705 SLEEP DISORDER 1 0.0000
706 THERAPY INTERRUPTED 1 0.0000
707 SKIN BURNING SENSATION 1 0.0000
708 CONSTIPATION 3 0.0000
709 HYPOAESTHESIA 2 0.0000
710 HOT FLUSH 1 0.0000
711 ACNE 1 0.0000
712 DRUG DOSE OMISSION BY DEVICE 1 0.0000
713 DRUG INTERACTION 2 0.0000
714 CARDIAC FAILURE 1 0.0000
715 PROSTATE CANCER 1 0.0000
716 THROMBOSIS 1 0.0000
717 TREATMENT FAILURE 1 0.0000
718 URTICARIA 2 0.0000
719 URINARY TRACT INFECTION 2 0.0000
720 BALANCE DISORDER 1 0.0000
721 MYOCARDIAL INFARCTION 2 0.0000
722 INTENTIONAL PRODUCT MISUSE 1 0.0000
723 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
724 DEVICE ISSUE 1 0.0000
725 DYSPHAGIA 1 0.0000
726 FATIGUE 8 0.0000
727 PAIN IN EXTREMITY 3 0.0000
728 SYNCOPE 1 0.0000
729 SOMNOLENCE 2 0.0000
730 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
731 DRUG INEFFECTIVE 12 0.0000
732 MUSCULAR WEAKNESS 1 0.0000
733 EMOTIONAL DISTRESS 1 0.0000
734 INJECTION SITE ERYTHEMA 1 0.0000
735 LOSS OF CONSCIOUSNESS 1 0.0000
736 DRY SKIN 1 0.0000
737 VISION BLURRED 1 0.0000
738 ARTHRALGIA 3 0.0000
739 DRUG DOSE OMISSION 1 0.0000
740 FALL 2 0.0000
741 CEREBROVASCULAR ACCIDENT 1 0.0000
742 MYALGIA 1 0.0000
743 BLOOD GLUCOSE INCREASED 1 0.0000
744 GAIT DISTURBANCE 1 0.0000
745 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
746 DEPRESSION 1 0.0000
747 INSOMNIA 1 0.0000
748 ANXIETY 1 0.0000